Desonide

Generic Name: Desonide

Brand Names: Desonate, Desowen, Desrx, Lokara, Tridesilon, Verdeso

Drug Type: Small Molecule

Chemical Formula: C_₂₄H_₃₂O_₆

CAS Number: 638-94-8

Unique Ingredient Identifier: J280872D1O

Overview

A nonfluorinated corticosteroid anti-inflammatory agent used topically for dermatoses.

Indication

For the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatose.

Associated Conditions

Dermatosis
Ocular Inflammation
Mild Atopic dermatitis
Moderate Atopic dermatitis

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Evaluation of the Vasoconstriction Properties of MC2-01 Cream	2018/11/29	NCT03758365	Phase 1	Completed	MC2 Therapeutics
Alternation in the Human Microbiome With Commonly Used Topical Medications	2018/02/19	NCT03437005	Phase 1	Recruiting	University of California, Davis
8-Week Atopic Dermatitis (AD) Treatment Study	2017/12/29	NCT03386032	Phase 3	Completed	Procter and Gamble
Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis	2016/04/08	NCT02732314	Phase 4	Completed	Procter & Gamble Beauty
Proton Pump Inhibitors Use in Patients With Psoriasis	2015/12/08	NCT02624544	Phase 4	Withdrawn	EMS
Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis	2014/11/10	NCT02286700	Phase 3	UNKNOWN	NeoStrata Company, Inc.
Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation	2012/03/02	NCT01542138	Phase 4	Completed	Universidad Autonoma de San Luis Potosí
Efficacy Emollient on Xerosis in Children With Atopic Dermatitis	2011/11/08	NCT01467362	Phase 3	Completed	Pierre Fabre Medicament
Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis	2009/01/26	NCT00828412	Phase 4	Completed	Promius Pharma, LLC

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
Desonide	Alembic Pharmaceuticals Inc.	62332-550	TOPICAL	0.5 mg in 1 mL	12/13/2023
Desonide	Alembic Pharmaceuticals Inc.	62332-632	TOPICAL	0.5 mg in 1 g	12/22/2023
Desonide Ointment, 0.05%	Bryant Ranch Prepack	72162-1272	TOPICAL	0.5 mg in 1 g	1/31/2024
desonide	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	0168-0309	TOPICAL	0.5 mg in 1 g	2/24/2016
Desonide	Teligent Pharma, Inc.	52565-038	TOPICAL	0.5 mg in 1 g	3/13/2019
Desonide	NORTHSTAR RX LLC	16714-729	TOPICAL	0.5 mg in 1 g	7/19/2023
Desonide	Actavis Pharma, Inc.	0472-0804	TOPICAL	0.5 mg in 1 g	8/26/2025
Desonide	Taro Pharmaceuticals U.S.A., Inc.	51672-1281	TOPICAL	0.5 mg in 1 g	1/31/2023
Desonide	Bryant Ranch Prepack	63629-2506	TOPICAL	0.5 mg in 1 g	5/19/2021
Desonide	Aleor Dermaceuticals Limited	71589-005	TOPICAL	0.5 mg in 1 g	11/30/2021

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
DESOWEN CREAM 0.05%	LABORATOIRES GALDERMA	SIN08252P	CREAM	0.05%	7/4/1995
DESOWEN LOTION 0.05%	LABORATOIRES GALDERMA	SIN08572P	LOTION	0.05%	2/13/1996

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
DESONIDE CREAM 0.05% W/W	N/A	bright future pharmaceuticals factory o/b bright future pharmaceutical laboratories limited	N/A	N/A	1/8/2025

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
DESOWEN desonide 0.5 mg/g lotion bottle	67182	Galderma Australia Pty Ltd	Medicine	A	12/21/1998
DESOWEN Desonide 0.5mg/g ointment tube	67174	Galderma Australia Pty Ltd	Medicine	A	12/21/1998
DESOWEN Desonide 0.5mg/g cream tube	67167	Galderma Australia Pty Ltd	Medicine	A	12/21/1998

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
TRIDESILON 0.05% DESONIDE CREAM	perrigo international	02154862	Cream - Topical	0.05 %	11/11/1996
TRIDESILON ONT 0.05%	miles canada inc. - pharmaceutical division	00521264	Ointment - Topical	.5 MG / G	12/31/1978
TRIDESILON 0.05% DESONIDE OINTMENT	perrigo international	02154870	Ointment - Topical	0.05 %	1/27/1998
PMS-DESONIDE	Pharmascience Inc	02516357	Ointment - Topical	0.05 % / W/W	N/A
PDP-DESONIDE	pendopharm division of pharmascience inc	02229315	Cream - Topical	0.05 % / W/W	1/14/1997
PMS-DESONIDE	Pharmascience Inc	02516349	Cream - Topical	0.05 % / W/W	N/A
DESOCORT OINTMENT - 0.05%	galderma canada inc	02115522	Ointment - Topical	.05 %	12/31/1994
DESOCORT LOTION - 0.05%	galderma canada inc	02115514	Lotion - Topical	.05 %	12/31/1994
DESOCORT CREAM 0.05%	galderma canada inc	02048639	Cream - Topical	.05 %	12/31/1994
VERDESO	GlaxoSmithKline Inc	02348489	Aerosol, Foam - Topical	0.05 %	4/20/2011

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

Related News

No news found

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.